20-44429456-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_175914.5(HNF4A):​c.1217-67C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.589 in 1,595,626 control chromosomes in the GnomAD database, including 279,916 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 24593 hom., cov: 28)
Exomes 𝑓: 0.59 ( 255323 hom. )

Consequence

HNF4A
NM_175914.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.378

Publications

13 publications found
Variant links:
Genes affected
HNF4A (HGNC:5024): (hepatocyte nuclear factor 4 alpha) The protein encoded by this gene is a nuclear transcription factor which binds DNA as a homodimer. The encoded protein controls the expression of several genes, including hepatocyte nuclear factor 1 alpha, a transcription factor which regulates the expression of several hepatic genes. This gene may play a role in development of the liver, kidney, and intestines. Mutations in this gene have been associated with monogenic autosomal dominant non-insulin-dependent diabetes mellitus type I. Alternative splicing of this gene results in multiple transcript variants encoding several different isoforms. [provided by RefSeq, Apr 2012]
HNF4A Gene-Disease associations (from GenCC):
  • maturity-onset diabetes of the young type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • monogenic diabetes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • diabetes mellitus, noninsulin-dependent
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, G2P
  • hyperinsulinism due to HNF4A deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 20-44429456-C-G is Benign according to our data. Variant chr20-44429456-C-G is described in ClinVar as Benign. ClinVar VariationId is 676886.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.602 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HNF4ANM_175914.5 linkc.1217-67C>G intron_variant Intron 9 of 9 ENST00000316673.9 NP_787110.2 P41235-5F1D8T0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HNF4AENST00000316673.9 linkc.1217-67C>G intron_variant Intron 9 of 9 1 NM_175914.5 ENSP00000315180.4 P41235-5

Frequencies

GnomAD3 genomes
AF:
0.567
AC:
85607
AN:
151020
Hom.:
24597
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.530
Gnomad AMI
AF:
0.609
Gnomad AMR
AF:
0.503
Gnomad ASJ
AF:
0.706
Gnomad EAS
AF:
0.353
Gnomad SAS
AF:
0.585
Gnomad FIN
AF:
0.578
Gnomad MID
AF:
0.717
Gnomad NFE
AF:
0.607
Gnomad OTH
AF:
0.584
GnomAD4 exome
AF:
0.591
AC:
853730
AN:
1444488
Hom.:
255323
AF XY:
0.593
AC XY:
426397
AN XY:
719238
show subpopulations
African (AFR)
AF:
0.529
AC:
17520
AN:
33126
American (AMR)
AF:
0.429
AC:
19133
AN:
44582
Ashkenazi Jewish (ASJ)
AF:
0.702
AC:
18219
AN:
25970
East Asian (EAS)
AF:
0.382
AC:
15095
AN:
39566
South Asian (SAS)
AF:
0.602
AC:
51605
AN:
85772
European-Finnish (FIN)
AF:
0.597
AC:
31792
AN:
53230
Middle Eastern (MID)
AF:
0.678
AC:
3771
AN:
5564
European-Non Finnish (NFE)
AF:
0.603
AC:
661551
AN:
1096890
Other (OTH)
AF:
0.586
AC:
35044
AN:
59788
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
16586
33173
49759
66346
82932
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17748
35496
53244
70992
88740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.567
AC:
85635
AN:
151138
Hom.:
24593
Cov.:
28
AF XY:
0.563
AC XY:
41530
AN XY:
73760
show subpopulations
African (AFR)
AF:
0.530
AC:
21800
AN:
41134
American (AMR)
AF:
0.503
AC:
7640
AN:
15198
Ashkenazi Jewish (ASJ)
AF:
0.706
AC:
2444
AN:
3464
East Asian (EAS)
AF:
0.353
AC:
1792
AN:
5078
South Asian (SAS)
AF:
0.584
AC:
2806
AN:
4802
European-Finnish (FIN)
AF:
0.578
AC:
5966
AN:
10316
Middle Eastern (MID)
AF:
0.705
AC:
206
AN:
292
European-Non Finnish (NFE)
AF:
0.607
AC:
41208
AN:
67860
Other (OTH)
AF:
0.585
AC:
1221
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1748
3496
5243
6991
8739
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
732
1464
2196
2928
3660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.583
Hom.:
3276
Bravo
AF:
0.558
Asia WGS
AF:
0.471
AC:
1639
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Maturity onset diabetes mellitus in young Benign:1
-
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Potent mutations in HNF4A are associated with poor insulin secretion in response to hyperglycemia. Associated with MODY1. Patients initially respond well to sulfonylureas but eventually become insulin dependent. However, more evidence is required to ascertain the role of this particular variant rs3746575 in MODY, yet. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.48
DANN
Benign
0.60
PhyloP100
-0.38
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3746575; hg19: chr20-43058096; COSMIC: COSV57380799; COSMIC: COSV57380799; API